FDA Releases Data On Performance Of COVID-19 Diagnostic Tests
- September 16, 2020
Bloomberg (9/16, Court) reports the FDA “released performance data late Tuesday for a slew of Covid-19 diagnostic tests, in an effort to help doctors, labs and patients evaluate competing products.” In order “to assess the products, the FDA shipped a standardized panel of samples to developers starting in May without disclosing how much viral material was in them.” The FDA “is now making the results of that blind test available, detailing how well more than 55 different screenings do in detecting infection.”